Valuation: HansBiomed Corporation

Market Cap 271B 204M 182M 168M 153M 287M 19.33B 291M 2.02B 793M 10.12B 765M 750M 32.27B P/E 2026 *
20.7x
P/E 2027 * 10.6x
Enterprise Value 301M 227K 202K 187K 170K 319K 21.5M 324K 2.25M 883K 11.25M 851K 834K 35.89M EV / Sales 2026 *
2.13x
EV / Sales 2027 * 1.33x
Free-Float
64.21%
Yield 2026 *
-
Yield 2027 * -
1 day-7.77%
1 week-4.67%
Current month-8.43%
1 month+4.86%
3 months-6.63%
6 months-42.94%
Current year-31.16%
1 week 17,030
Extreme 17030
22,300
1 month 17,030
Extreme 17030
23,750
Current year 15,300
Extreme 15300
57,800
1 year 15,300
Extreme 15300
57,800
3 years 6,180
Extreme 6180
57,800
5 years 6,180
Extreme 6180
57,800
10 years 6,180
Extreme 6180
57,800
Manager TitleAgeSince
Chief Executive Officer 63 2018-11-30
Sales & Marketing 47 -
Comptroller/Controller/Auditor 60 2017-12-05
Director TitleAgeSince
Director/Board Member 67 1999-08-31
Director/Board Member 63 2018-11-30
Director/Board Member 56 2019-12-25
Date Insider Type Main position Quantity % Market Cap. Importance
1/7/25 Others 2,500 0.0185%
Change 5-day change 1-year change 3-year change Capi.($)
-7.77%-4.67%-18.45%+30.14% 204M
-1.55%-0.16%-20.89%+5.86% 177B
+2.17%+7.73%-20.15%+14.57% 117B
+2.00%+1.74%-1.34%+30.17% 116B
+14.58%+16.51%-45.50%+4.26% 77.71B
+0.96%+3.99%+4.85%+81.86% 65.51B
+1.98%+4.35%+15.64%+82.79% 54.97B
+1.60%+3.43%+1.47%-25.07% 52.79B
+0.38%+7.23%-13.29%+30.66% 43.95B
-0.28%+0.80%+25.30%-0.27% 32.35B
Average +1.48%+2.98%-7.24%+25.50% 73.74B
Weighted average by Cap. +2.33%+3.03%-11.21%+22.38%

Financials

2026 *2027 *
Net sales 142B 107M 94.98M 88.03M 79.77M 150M 10.11B 152M 1.06B 415M 5.29B 400M 392M 16.88B 202B 152M 135M 125M 113M 213M 14.37B 217M 1.5B 590M 7.52B 569M 557M 24B
Net income 13B 9.79M 8.71M 8.08M 7.32M 13.75M 927M 13.98M 96.9M 38.07M 485M 36.72M 35.96M 1.55B 25.4B 19.13M 17.03M 15.78M 14.3M 26.87M 1.81B 27.32M 189M 74.38M 948M 71.75M 70.26M 3.03B
Net Debt 30.4B 22.89M 20.38M 18.89M 17.11M 32.16M 2.17B 32.7M 227M 89.02M 1.13B 85.87M 84.09M 3.62B -3B -2.26M -2.01M -1.86M -1.69M -3.17M -214M -3.23M -22.36M -8.79M -112M -8.47M -8.3M -357M
Projected Income Statement - Annual - HansBiomed Corporation
Logo HansBiomed Corporation
Hans Biomed Corp is a Korea-based company primarily engaged in the biotechnology industry. The Company is mainly engaged in the medical devices business, including skin and bone grafts for human transplantation, facial tissue fixation sutures, and silicone products. In addition, the Company is engaged in the provision and sale of medical devices, bone grafts, skin grafts, and silicone products.
Employees
315
Date Price Change Volume
26-10-20 ₩19,000.00 -7.77% 103,356
26-10-19 ₩20,600.00 -5.50% 91,073
26-10-16 ₩21,800.00 +25.36% 325,864
26-10-15 ₩17,390.00 -8.95% 94,406
26-10-14 ₩19,100.00 -4.16% 135,712
Trader
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - HansBiomed Corporation

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - HansBiomed Corporation
  1. Stock Market
  2. Stocks
  3. A042520 Stock